Our previous work demonstrated that low/absent TRPML1 expression is strongly correlated with short survival in patients with glioblastoma, suggesting that the reduction of TRPML1 mRNA expression represents a negative prognostic factor (33). This evidence concerns the gene MCOLN1 and glioblastoma.